M&A Deal Summary |
|
---|---|
Date | 2017-01-08 |
Target | Merrimack Pharmaceuticals - Oncology Assets |
Sector | Life Science |
Buyer(s) | Ipsen |
Sellers(s) | Merrimack Pharmaceuticals |
Deal Type | Divestiture |
Deal Value | 575M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1929 |
Sector | Life Science |
Employees | 5,325 |
Revenue | 3.3B EUR (2023) |
Ipsen is a research and development pharmaceutical company. It manufactures specialty pharmaceuticals and has a worldwide sales presence. Ipsen focuses on products in the gastro-enterology, neurology and cardiovascular therapeutic areas and has also developed specific expertise in some biotech niches such as endocrinology, oncology, neurology and hematology. Ipsen was founded in 1929 and is based in Boulogne-Billancourt, France.
DEAL STATS | # |
---|---|
Overall | 6 of 11 |
Sector (Life Science) | 6 of 11 |
Type (Divestiture) | 1 of 2 |
State (Massachusetts) | 1 of 3 |
Country (United States) | 3 of 5 |
Year (2017) | 1 of 3 |
Size (of disclosed) | 2 of 5 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-02-24 |
Canbex Therapeutics
London, United Kingdom Canbex Therapeutics Ltd. develop its proprietary VSN compound series in spasticity and other unmet medical needs. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-01-31 |
Akkadeas Pharma Srl
Milano, Italy Akkadeas Pharma Srl is a privately-held consumer health care company in Italy with a diversified gastrointestinal-focused portfolio including probiotics, medical devices and food supplements. |
Buy | - |
Category | Company |
---|---|
Founded | 1993 |
Sector | Life Science |
Merrimack Pharmaceuticals, Inc. is a bio-pharmaceutical company develops commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (Massachusetts) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2017) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2009-12-07 |
HERMES Biosciences
South San Francisco, California, United States HERMES Biosciences, Inc. develops targeted drug delivery technologies for therapeutic and other biomedical applications. |
Buy | - |